A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse
β Scribed by Tribhawan Vats; George Buchanan; Paulette Mehta; Abdal Ragab; Eva Hvizdale; Ruprecht Nitschke; Michael Link; G. Peter Beardsley; David Maybee; Jeffrey Krischer
- Publisher
- Springer US
- Year
- 1992
- Tongue
- English
- Weight
- 262 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Second remission induction rates for vincristine and prednisone alone (VP) and vincristine, L-asparaginase, and prednisone (VLP) are compared for children with acute lymphocytic leukemia. No evidence of a significant difference between the second induction complete remission rate for VP (78.6%) and
## Abstract Although the majority of children with acute lymphoblastic leukemia (ALL) can electively stop treatment after 21/2β5 years of continuous diseaseβfree remission, 20β25% of those patients relapse after discontinuation of therapy. We treated 15 patients whose disease recurred after stoppin
Although the chance of cure for children with acute lymphoblastic leukaemia (ALL) is high, their outlook with subsequent relapse is poor. Bone marrow transplantation may be an option for some, but the need for intensive reinduction chemotherapy regimens remains the best hope for effecting cure in th